4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-22-013142
Chairman & CEO bought 232,500 shares at an average $4.96 ($1,153,145)
From the SEC's structured data for this filing
Trades in this filing
BENTSUR RON · Chairman & CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-04 | Purchase : show line 1 in the form | +200,000 | $5.00 | $1,000,000 | 2,765,459 | D |
| 2022-02-04 | Purchase : show line 2 in the form | +12,500 | $3.89 | $48,625 | 2,777,959 | D |
| 2022-02-07 | Purchase : show line 3 in the form | +14,000 | $3.93 | $55,020 | 2,791,959 | D |
| 2022-02-07 | Purchase : show line 4 in the form | +6,000 | $8.25 | $49,500 | 2,797,959 | D |
| Open-market purchases · 232,500 sh · avg $4.96 · $1,153,145 | ||||||
Loading xslF345X03/tm225864-1_4.xml…